Category: Business
The Center’s Flagship Investment Program provides working capital to early-stage companies
For Immediate Release: Date: February 24, 2010
Contact: Angus G. McQuilken, MLSC VP for Communications
Phone: (617) 921-7749 Email: amcquilken@masslifesciences.com
Waltham, MA – The Board of Directors of the Massachusetts Life Sciences Center today approved the launch of the 2010 Accelerator Loan Program, the second year of the Center’s flagship investment program that provides working capital to early-stage life sciences companies. The Center will begin accepting online applications on Wednesday, February 24th, 2010 with an application deadline of Wednesday, March 24, 2010. A subsequent round will be conducted in the fall, with application dates to be announced. Applications will be accepted via the Center’s web site at www.masslifescience.com.
The Program has been capitalized with $5.5 million for 2010. This year’s program will offer loans of up to $750,000 per company, an increase from the 2009 maximum loan amount of $500,000. The Program seeks to “de-risk” start-up companies that are in need of financing to serve as flexible working capital or for the purchase of capital assets to help selected companies achieve product development milestones and obtain private investment. In addition, the loan terms will now include a warrant which will give the Center the right to purchase equity in the company at a specific price within a certain time frame.
 |
|
...But what do I know?
Lessons learned from living through a couple of spin-out companies
|
|
qed@qb3 UCSF
Thursday, March 4, 2010
12:00 to 1:00 pm
Byers Hall Room 212
|
There are many lessons to be learned in the formation of spinouts. Tom will walk through his experiences going from an academic setting to a spinout company and what he has learned from this and a couple of other companies that he has been close to (Avantome, TrueMaterials, Boreal Genomics)
Tom Willis is the CEO of MLC Dx Inc. a VC backed company dedicated to the commercialization of molecular diagnostic tests. Prior to founding MLC, Tom has been an entrepreneur in the biotech industry for the past decade. After receiving his Ph.D. in physics from Stanford University, he joined the Stanford Genome Technology Center (SGTC) to work on DNA sequence analysis technologies. He held several positions at the SGTC including Associate Director in charge of technology development. While at SGTC, he co-invented the Molecular Inversion Probe technology for high throughput genotyping. In 2001, he co-founded ParAllele BioScience to develop and commercialize this technology. As its founding CEO, he led ParAllele through two rounds of VC financing a grew the company to over 80 employees. In 2005 ParAllele was acquired by Affymetrix at which time Tom served in several management positions at Affymetrix. He left in 2007 to pursue new startup opportunities. In addition to his role at MLC, Tom serves on the boards of SpinX Technologies and Boreal Genomics
Lunch provided, but space is limited so please reserve a seat at http://www.acteva.com/booking.cfm?bevaID=198455
http://qb3.org/services/qed-qb3/?searchterm=qed
Date: March 2, 2010
Time: 12:00PM-2:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Registration Cost: from $0 to $40
The achievement of a cleared Investigational New Drug application (IND) is a critical milestone for most small to mid-sized companies. Senior Management teams face many challenges when working on these applications. These are not easy applications to create, and there are many potential pitfalls. During this presentation the pitfalls that CEOs and senior management teams need to be aware of will be identified. A panel session will follow the main presentation at which time the audience will be able to address questions to members of the panel. Webinar link-up is available for those who are not able to participate on-site. Please indicate if you would like to join by webinar when signing up. The details for the webinar will be sent to participants before the event. | Registration fee: from $0 to $40 | 12:00-2:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Speakers: Debra Gosling, Account Executive, Regulatory & Clinical Services, Liquent Inc. | Tom Delisi, Senior Consultant, Regulatory Services, Liquent Inc. | Kathryn Plank, Senior Regulatory Consultant, Liquent Inc. | Jim Hilferty, Operations Manager, Regulatory & Clinical Services, Liquent Inc.
|
|
Building, Compensating & Motivating
a Leadership Team
|
|
qed@qb3 - UCSF
Thursday, February 4, 2010
12:00 to 1:00 pm
Byers Hall Room 212
|
One of the most critical factors for a company's success is building an excellent team, but finding, recruiting, compensating, and ultimately motivating the best people is extremely challenging. Chris McKinley and Michael Ballenger bring decades of HR and executive recruitment experience to this subject and will share their insights and advice in this seminar.
Christine McKinley has 30 years experience working in entrepreneurial, high growth biotech and medical companies. Prior to founding Round One Resources, she was Sr.VP of Human Resources at Cell Genesys, responsible for strategic and operational HR initiatives, involving extensive staffing of a manufacturing facility, expansion of process development, manufacturing and clinical operations, merger, acquisition and restructuring activities. She began as one of the earlier employees of Genentech.
Michael Ballenger specializes in Board of Director, CEO searches as well as officer-level assignments in research, product development and all business functions. He has 23 years of experience in executive search in all segments of the life science/healthcare product industry and has focused his last 10 years on work with start-up and development stage companies. He was previously the Managing Partner of Highland Partner's San Francisco office where he built the company's first Life Science/Healthcare Products Practice and was also Sr. Director of Human Resources for Genentech.
Lunch provided, but space is limited so please reserve a seat at http://www.acteva.com/booking.cfm?bevaID=197756
 |
|
Grantwriting 101
including SBIR and STTRs
|
|
qed@qb3 - UCB
Friday, February 5, 2010
12:00 to 1:00 pm
Stanley Hall Room 621
|
SBIR/STTR grants can provide the critical funding necessary to launch your company. But success requires mastering the tricks of the SBIR/STTR program, some of which have frustrated excellent groups. From where to register to uploading your proposal, we'll cover the ins and outs of preparing grants for the NIH. This seminar is aimed at new and experienced grantwriters, from academia and industry. Even veteran grantwriters will benefit from a review of the new formats required as of January 2010.
Shauna Farr-Jones has a 10-year record of writing successful government grant and contract proposals on diverse life science topics, providing strategic input on both research and business plans. She has helped companies secure over $125 million in grant and contract funding from government and philanthropic agencies. Previously, she was at BioCentury Publications, where she analyzed the biotechnology industry. She was a postdoc in PharmChem at UCSF after a Ph.D. in Biochem from Tufts.
Amy F. Boggs is an independent consultant with more than 8 years experience in grant-writing. She also handles the preparation of technical reports, INDs and NDAs, technology assessment, strategic research planning, and competitive landscaping. Prior, Dr. Boggs worked at Microcide and at IntraBiotics, where she managed an interdisciplinary technology in-licensing team. Dr. Boggs is an inventor on three issued patents and has worked on IND-enabling projects. She completed a Ph.D. in PharmChem at UCSF under Dr. Agard.
Lunch provided, but space is limited so please reserve a seat at http://www.acteva.com/booking.cfm?bevaID=197134
Bread Board's NextFab Studio opened January 22, allowing students, adults, researchers and companies to fabricate and prototype novel designs in 3D. NextFab and Bread Board's Esther Klein Gallery which had an opening for the Brower Jet Propulsion Laboratory in conjunction with the open house, brought the public into the Science Center to share in the excitement and possibility that is always present.
The 3,600 square foot production space much like the gallery across the street meets a number of needs. It provides access to the materials that will generate both conceptual and physical innovation, so that the life cycle of information and commerce may perpetuate.
Contact
Jeanne Mell
University City Science Center
215-966-6029
PHILADELPHIA--(January 20, 2010) – Saul Behar has joined the University City Science Center as Vice President and General Counsel. Behar has worked for the Science Center as a consultant since January 2009. He reports directly to Stephen S. Tang, Ph.D., the Science Center’s President and CEO. In addition to his role as General Counsel, Behar also has responsibility for government relations at the federal, state and city levels.
Behar brings to his new position nearly 25 years of experience as an attorney, senior executive and strategic advisor, managing sophisticated corporate, real estate and securities transactions for both early-stage and established companies in diverse fields. Most recently, Behar was a partner at Wolf Block LLP in Philadelphia. Prior to that, he served as General Counsel at Provident Senior Living Trust, a privately owned real estate investment trust based in Princeton, New Jersey that owned 68 senior housing facilities in 19 states. Before joining Provident, Behar served as General Counsel at Keystone Property Trust, an NYSE-listed real estate investment trust headquartered in West Conshohocken, Pennsylvania that focused on industrial real estate. Provident and Keystone were highly successful real estate firms that were acquired by the leading companies in their industry sectors.
For Immediate Release
Contact TREO:
Laura Shaw, Sr. Vice President, Marketing and Communications
Contact Bell Independent Power Corp.:
Joseph Bell Jr., President
Contact UA Tech Park:
Jessa Turner, Media & Public Relations Coordinator
Tucson, AZ (January 19, 2010) – Bell Independent Power Corp., Rochester, New York, is a developer of Thermal Storage Technology for Concentrated Solar Power (CSP). Bell has chosen the UA Tech Park as the site of a new state of the art 5-MW solar plant with a Thermal Storage System that will be the first of its kind in the world.
The Chicago Technology Park exists as part of the larger Illinois Medical District to provide a home to the many businesses generated or attracted by the research and care provided through the District. The Research Center is the Technology Park’s business incubator where young companies and their cohort of partners may build businesses around innovation. The biotech incubator supports entrepreneurs with a network of consortia to fund and direct growth for success.
Workforce Development Program will provide internship opportunities for Massachusetts students and recent graduates in summer 2010
For Immediate Release: Date: January 12, 2010
Contact: Angus G. McQuilken, Life Sciences Center VP for Communications
Phone: (617) 921-7749 Email: amcquilken@masslifesciences.com
Waltham, MA – The Massachusetts Life Sciences Center today announced the launch of the Center’s Internship Challenge Program for the summer of 2010, the second year of a workforce development program focused on enhancing the talent pipeline for Massachusetts life sciences companies. The program will provide paid internship opportunities at life sciences companies for up to 150 students and recent college graduates who are considering career opportunities in the life sciences.
